$109 Million is the total value of BML Capital Management, LLC's 26 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BIL | SPDR SER TRbloomberg 1-3 mo | $18,364,000 | 0.0% | 200,000 | 0.0% | 16.86% | +2.1% | |
| TALS | TALARIS THERAPEUTICS INC | $5,620,000 | -7.6% | 2,000,000 | 0.0% | 5.16% | -5.6% | |
| ASTROTECH CORP | $2,226,141 | -28.7% | 220,410 | 0.0% | 2.04% | -27.2% | ||
| ABIO | ARCA BIOPHARMA INC | $1,420,929 | -1.0% | 706,930 | 0.0% | 1.30% | +1.1% | |
| PASG | PASSAGE BIO INC | $1,354,669 | -30.1% | 2,058,767 | 0.0% | 1.24% | -28.6% | |
| MIST | MILESTONE PHARMACEUTICALS IN | $844,750 | +8.8% | 272,500 | 0.0% | 0.78% | +11.0% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $582,750 | -32.7% | 150,000 | 0.0% | 0.54% | -31.3% | |
| LISATA THERAPEUTICS INC | $521,815 | -42.2% | 243,839 | 0.0% | 0.48% | -41.0% | ||
| NXTC | NEXTCURE INC | $395,340 | -28.3% | 306,465 | 0.0% | 0.36% | -26.8% | |
| CALCIMEDICA INC | $236,113 | -33.7% | 88,781 | 0.0% | 0.22% | -32.2% | ||
| RAIN | RAIN ONCOLOGY INC | $62,848 | -28.2% | 72,926 | 0.0% | 0.06% | -26.6% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR SER TR | 4 | Q3 2023 | 16.9% |
| ADVERUM BIOTECHNOLOGIES INC | 4 | Q3 2023 | 7.4% |
| ELIEM THERAPEUTICS INC | 4 | Q3 2023 | 6.4% |
| ATHIRA PHARMA INC | 4 | Q3 2023 | 4.9% |
| ASTROTECH CORP | 4 | Q3 2023 | 2.8% |
| ARCA BIOPHARMA INC | 4 | Q3 2023 | 1.9% |
| FORTE BIOSCIENCES INC | 4 | Q3 2023 | 1.6% |
| VERRICA PHARMACEUTICALS INC | 4 | Q3 2023 | 2.9% |
| PASSAGE BIO INC | 4 | Q3 2023 | 1.7% |
| RETRACTABLE TECHNOLOGIES INC | 4 | Q3 2023 | 1.0% |
View BML Capital Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-04-24 |
| 13F-HR | 2024-04-23 |
| 13F-HR/A | 2024-02-02 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-23 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-04-14 |
| 13F-HR | 2023-02-13 |
View BML Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.